FDA is now accepting
Public Comments on Librela
We have officially filed a Citizen Petition with the FDA asking for a comprehensive review of
Librela and related monoclonal antibody veterinary drugs.
The FDA is now accepting public comments and your voice is critical!!
If you've lost a dog, experienced an adverse event, had concerns, or simply believe pet owners deserve complete transparency before making medical decisions, please take two minutes and submit a comment.
The level of public engagement during public comment window is significant—petitions that generate substantial, substantive public comments tend to receive greater regulatory attention than those with limited participation. YOUR VOICE MATTERS!
This is your opportunity to be heard
Takes less than 2 minutes
Comments become part of the official FDA record.
Citizen Petition
What is a Citizen Petition?
A Citizen Petition is a formal request submitted to the FDA asking the agency to take a specific regulatory action, such as reviewing safety data, updating labeling, or changing oversight of an approved product. The FDA is required by law to review the petition and issue a formal response, typically within 180 days of submission.
It becomes part of the official administrative record and requires the FDA to evaluate the issues raised and issue a formal response.
On June 1, 2026, the Pharmaceutical Safety Oversight Council (PSOC), the regulatory advocacy arm of Paws Over Profits, filed a formal Citizen Petition with the FDA regarding Librela and related monoclonal antibody veterinary drugs.
Why Public Comments Matter
Be heard by an agency that can take action
Become part of official FDA administrative record
Reviewed during regulatory evaluation of the petition
Reflect real-world experiences and observations
Inform transparency and safety oversight considerations